Clinical Trial

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine whether Apixaban is effective and safe in the treatment of portal vein thrombosis Occurring more than one year after laparoscopic splenectomy and azygoportal disconnection.
Protocol Amendment History 4 changes
critical Primary endpoint(s) modified 2026-04-01
notable Enrollment reduced: 40 -> 20 participants 2026-04-01
notable Primary completion pushed: 2026-03-20 -> 2027-09-30 2026-04-01
minor Completion pushed: 2027-08-01 -> 2027-09-30 2026-04-01
Trial Details
NCT Number NCT07461532
Lead Sponsor Northern Jiangsu People's Hospital
Conditions Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal
Enrollment 20 participants
Start Date 2026-04-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-31